UK consortium launches COVID-19 Protein Portal to provide essential reagents for SARS-CoV-2 research
12 May 2020
A new initiative, led by Wellcome and UKRI, will allow UK scientists to access protein reagents needed for critical research relating to SARS-CoV-2 free of charge from a consortium of leading protein production laboratories.
In response to the urgent need for COVID-19 therapeutics, vaccines and diagnostics, many UK scientists are working to understand the fundamental biology of SARS-CoV-2. Reliable protein reagents are crucial to such research, but can be challenging and time consuming to produce, especially under restricted working conditions.
Wellcome and UKRI have brought together a consortium of leading centres of protein engineering and production to launch the COVID-19 Protein Portal.